Company Filing History:

8 out of 67

Tibotec Pharmaceuticals Ltd.

where one patent can have more than one assignee

Years Active: 2007-2014

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8673551 - Methods, plasmid vectors and primers for assessing HIV viral fitness (2014-03-18),

2. 8592161 - Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance (2013-11-26),

3. 8076062 - Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance (2011-12-13),

4. 8036861 - Method and means for determining the replication rate of a viral population (2011-10-11),

5. 7863306 - Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors (2011-01-04),

6. 7622490 - Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors (2009-11-24),

7. 7595334 - Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors (2009-09-29),

8. 7429677 - Small molecule entry inhibitors (2008-09-30),

9. 7244752 - Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors (2007-07-17),

10. 7217506 - Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance (2007-05-15),

Title: The Innovations of Marie-Pierre T M M G De Bethune

Introduction

Marie-Pierre T M M G De Bethune is a notable inventor based in Everberg, Belgium. He has made significant contributions to the field of HIV research, holding a total of 10 patents. His work focuses on methods and technologies that enhance the understanding and treatment of HIV.

Latest Patents

One of his latest patents is titled "Methods, plasmid vectors and primers for assessing HIV viral fitness." This invention relates to methods for evaluating HIV replicative capacity in various environments. It provides a growth competition assay that determines relative viral fitness using a recombinant tagged HIV-1 virus system. The methods utilize plasmid vectors, amplicons, primers, and probes to generate replication-competent viruses. These innovations have potential applications in diagnostics, drug screening, pharmacogenetics, and drug development.

Another significant patent is "Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance." This invention focuses on nucleic acid diagnostics and the identification of base variations in target nucleic acid sequences. It aims to correlate virus mutational profiles with drug resistance, which can be crucial for drug discovery, design, modification, and treatment strategies.

Career Highlights

Marie-Pierre has worked with prominent companies in the pharmaceutical industry, including Tibotec Pharmaceuticals Ltd. and Janssen R&D Ireland. His experience in these organizations has allowed him to contribute to groundbreaking research and development in HIV treatment.

Collaborations

Throughout his career, Marie-Pierre has collaborated with esteemed colleagues such as Abdellah Tahri and Dominique Louis Nestor Ghislain Surleraux. These partnerships have fostered innovation and advancement in their shared field of research.

Conclusion

Marie-Pierre T M M G De Bethune is a distinguished inventor whose work has significantly impacted HIV research and treatment. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com